findmyKOL
Clinical trialNCT01619046UnknownPhase 3Interventional

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

SponsorGreen Cross CorporationEnrollment124Hemophilia A
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Paul LeoFrancis Giangrande, MD

    Oxford Haemophilic Centre and Thrombosis Unit, Churchill Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Alberta

    Edmonton, Alberta, Canada

    Bruce Ritchie
    Recruiting
  • Mcmaster Children'S Hospital

    Hamilton, Ontario, Canada

    Anthony Chan
    Recruiting
New Zealand
  • Research Associates, Ltd.

    Christchurch, New Zealand, New Zealand

    Mark Smith, M.D.
    Recruiting
Poland
  • Instytut Hematologii I Transfuzjologii

    Warsaw, Poland

    Marcin Pasiarski, M.D.
    Recruiting
  • Wojewodzki Szpital Specjalistyczny, Klinika Hematologii Uniwersytetu Medycznego W Łodzi

    Łodzi, Poland

    Krzysztof Chojnowski, M.D.
    Recruiting
Russia
  • Barnaul Altai State Scientfic Center

    Barnaul, Russia

    A Mamaev, M.D.
    Recruiting
  • Kirov Research Institute of Hematology and Blood Transfusion

    Kirov, Russia

    M Timofeeva, M.D.
    Recruiting
  • Ismailov City Children'S Clinical Hospital of Board of Health of Moscow City

    Moscow, Russia

    Vladimir Vdovin, M.D.
    Recruiting
  • State Budget Educational Institution of Higher Professional Education "samara State Medical University" of the Ministry of Health and Social Process of the Russian Federation

    Samara, Russia

    Igor Davydkin, M.D.
    Recruiting
  • Ufa Republican Clinical Hospital

    Ufa, Russia

    G Gaysarova, M.D.
    Recruiting
Ukraine
  • Dnepropetrovsk City Clinical Hospital

    Dnipro, Ukraine

    Y Shinkarenko, M.D.
    Recruiting
  • Institute of Urgent and Reconstructive Surgery Named After V.K. Gusak of National Academy of Medical Sciences of Ukraine

    Donetsk, Ukraine

    Ekaterina Vilchevska
    Recruiting
  • Kharkov Regional Clinical Oncology Center

    Kharkiv, Ukraine

    Tetyana Poposvka, M.D.
    Recruiting
  • Kyiv City Clinical Hospital No 91

    Kyiv, Ukraine

    Ievgenii Averianov
    Recruiting
  • Institute of Blood Pathology and Transfusion Medicine of National Academy of Medical Sciences of Ukraine Department of Surgery and Clinical Transfusiology

    Lviv, Ukraine

    Oleksandra Stasyshyn
    Recruiting
  • Zaporizhzhya Region Clinical Child Hospital

    Zaporzhye, Ukraine

    A Borodin, M.D.
    Recruiting
United Kingdom
  • Royal Cornwall Hospital, Department of Haematology

    Truro, Cornwall, United Kingdom

    Desmond Creagh
    Recruiting
  • Hull Haemophillia Centre, Hull Royal Infirmary

    Humberside, Hull, United Kingdom

    David Allsup, M.D.
    Recruiting
  • Central Manchester University Hospitals

    Manchester, Lancashire, United Kingdom

    Charles Hay
    Recruiting
  • St. Thomas' Hospital

    City of Westminster, London, United Kingdom

    Graeme Thomson, M.D.
    Recruiting
  • North Hampshire Haemophilia Centre

    Basingstoke, North Hampshire, United Kingdom

    Savita Rangarajan
    Recruiting
  • University of Liverpool

    Liverpool, United Kingdom

    Tina Dutt, M.D.
    Recruiting
  • Royal Free Hospital, Haemophilia Centre & Thrombosis Unit

    London, United Kingdom

    Pratima Chowdary, M.D.
    Recruiting
  • Churchill Hospital, Oxford

    Oxford, United Kingdom

    Paul Giangrande, M.D.
    Recruiting
United States
  • Arkansas Children'S Hospital

    Little Rock, Arkansas, United States

    Kimo Stine, MD
    Recruiting
  • Los Angeles Orthopaedic Hospital - Hemophilia Treatment Center

    Los Angeles, California, United States

    Doris Quon, M.D.
    Recruiting
  • Harbor - Ucla Pediatrics

    Torrance, California, United States

    Joseph Lasky, M.D.
    Recruiting
  • University of Miami - Comprehensive Hemophilia Center

    Miami, Florida, United States

    Joanna Davis, M.D.
    Recruiting
  • St. Luke'S Boise Medical Center

    Boise, Idaho, United States

    Eugenia Chang, M.D.
    Recruiting
  • Rush University Medical Center

    Chicago, Illinois, United States

    Lisa Boggio, M.D.
    Recruiting
  • Michigan State University Center for Bleeding Disorders & Clotting Disorders

    East Lansing, Michigan, United States

    John Penner, M.D.
    Recruiting
  • Children'S Mercy Hospital - Kansas City Regional Hemophilia Center

    Kansas City, Missouri, United States

    Brian Wicklund, M.D.
    Recruiting
  • Long Island Jewish Medical Center - Hemophilia Treatment Center

    New Hyde Park, New York, United States

    Richard Lipton, M.D.
    Recruiting
  • Oregon Health and Science University

    Portland, Oregon, United States

    Michael Recht, M.D.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2013
Primary completion
31 Jul 2015
Completion
30 Sept 2015
Last update posted
3 Jul 2014
Registered enrollment
124
Registry id
NCT01619046

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.